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Ancient Beginnings of Snails and Potential
Application to CAM
The land helix, or snail, has been used in medicine since
antiquity and prepared according to several formulations. The
therapeutic properties of snails were thought to come from
their holy strength. ‘Associated with femininity and fertility,
curative properties are given to snails to treat associated
diseases’(1). Hippocrates proposed snail mucus against proto-
coele. Celse considered crude snail, i.e. snail crushed with its
shell, as a healing substance. Boiled, it is supposed to have
emollient properties. Pliny thought that snail increased the
speed of delivery. Reduced to a pulp, ‘it is a sovereign remedy
to treat pain related to burns, abscesses and other wounds’.
Pliny also recommended snails for nosebleed and stomach
pain, and many other pathological conditions: ‘female scrofula
can be cured with very dry and peeled old snails. To patients
with stomach pains, one must prescribe snails that were boiled
and grilled over a coal fire, and should be eaten with wine.
Snails from Africa are the best, but they must be prepared in an
uneven number. Those who spit up blood feel much better if
they drink snails. Eating snails was prescribed for individuals
suffering from vertigo, fainting fits, and fits of madness. The
snails should be crushed in the shell and heated with wine’(2).
Pliny finally directed: ‘arrows, darts that have to be extracted
from the body are attracted outside by applying a rat or a lizard
that is cut down the middle. Snails which are attached in
groups on the leaves of trees are crushed, as well as snails in
their shells, and applied for the same reason to the wound’(3).
Galien recommended snails against hydrops fetalis. Antiquity
expanded the idea that the snail has an instinctive knowledge
of some remedies: ‘A snail’, said Ambrose, ‘when eating snake
intestines and feels the penetration of poison, cures itself with
oregano and when a snail is in a swamp, it is able to find the
appropriate antidote and knows the power of saving herbs’(4).
Closer to us, Ambroise Paré recommended snails against
anthrax (5). Snail water is also present in the Universal
Pharmacopoeia, written by Lemery in 1738, in France: ‘One
leaves snails in their shells, washes them, and then crushes
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Baron-Barthelemy discussed the therapeutic properties of
helicine: ‘The opinion of the famous pharmacologist Barbier
seems essential for us on the subject. It is always observed, he
said, that in the slow inflammation of pulmonary organs, snail
preparations have sometimes decreased the morbid activity,
stopped its progression, and finally destroyed the disease’(10).
Baron-Barthelemy listed the numerous indications of these
snail preparations: ‘They have been used with success 
against most inflammations, and especially against cold and
cough, bronchitis, catarrhs, asthma, various types of haemop-
tysis, tonsilitis, pharyngitis, hoarseness, sore throat, influenza,
croup, whooping cough, nervous cough of children, lung
diseases such as pneumonia and pulmonary phthisis, nervous
stomach and intestinal cramps, gastritis, gastro-enteralgia,
headaches coming from a pathological disorder of the stomach,
cough that follows or comes with inflammatory skin diseases
such as: the measles, scarlet fever, small pox, erysipelas, and
so on, prolonged diseases with irritation and weakening, and
some skin diseases’.
Singer finds them to be very active aids against several alter-
ations of the voice. The same year, 1855, the author adds onto
the first report with a second one where several physicians or
patients testify to the efficacy of such preparations (11).
Dorvault also mentioned Dr Chrestien, from Montpellier
(France), who explains, concerning snail paste from Mure’s
company (based in Pont St Esprit, Gard, France): ‘During the
50 years that I have practiced medicine, I have not found a rem-
edy more efficient than snails against chest irritations’ (9).
During the same time, the Bouchardat formulary (another
reference book at that time) mentioned Figuier snail paste and
Chrestien snails (12). The encyclopaedic dictionary for medical
sciences in 1886 describes this therapeutic usage of helix and
adds: ‘One still makes a saccharum with a snail species com-
monly called littorine or sea snail, that was previously related
to the Helix genus now known as Littorina littorea L. One
keeps this preparation in a well sealed bottle’ (13). However,
this interest in snails did not stop at the end of the 19th century.
20th Century:Therapeutic and Biological
Properties of Snails are Confirmed
The 1945 edition of Dorvault still devotes an entire paragraph
to snails, indicating that the therapeutic usage of snails was
still alive. Although one could think that this was the end of
the medical career of snails, this was indeed not the case, since
several scientific articles re-launched the subject once again.
In France, Quevauviller prepared a relatively exhaustive
review of snail therapeutic properties in 1953 and related the
use of snail syrup in the 1920s for patients with chronic bron-
chitis (14). The author emphasized that ‘if no one even thinks
about using such a therapy for tuberculosis, recent research has
confirmed the sedative properties of several formulations
based on Helix pomatia for whooping cough and chronic
bronchitis, related to the antispasmodic and fluidizing proper-
ties of the secretions’. For the first time, the actual preparation
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them in a marble mortar. They are placed in a large glass jar,
positioned on a bain-marie, into which the fresh milk of a
female donkey is poured. The whole is mixed well with a
wooden spatula, and then left for digestion for 12 h before it is
distilled. The resulting distilled water is exposed to the sun for
several days in a glass bottle, and then kept in the bottle. This
is a hydrator, and is refreshing, useful for skin redness, and can
be used to clean up one’s face… It can also be used internally
for the spasms of spitting blood accompanying tuberculosis,
and for the urine ardour of nephritis. The dosage is between
one and six ounces’ (6).
19th Century: Pharmaceutical and Medical
use of Snails
The 19th century saw a renewed interest in the pharmaceutical
and medical use of snails. One can see this more specifically
with the work of George Tarenne who, in 1808, published a
book on snails and their ability to cure hernias (7). Speaking of
snail juice,Tarenne indicated that ‘its viscosity, its contraction or
astringent strength, and its capability for reproduction allowed
me immediately to suppose that it would close hernia openings’.
In 1817, the New Natural History Dictionary stated that ‘one
can pick up snails for use in Medicine and are recommended as
a broth for the throat and a smoother mixture is good for females
and can be used to keep the surface of the skin smooth and
brilliant.’At that time, snails were stringed as rosaries and were
used as shop signs for pharmacies. The work of Figuier in 1840
is also worthy of note. Quoting E. Soubeiran, he wrote, ‘Snails
contain an animalized mucilage, although not well known from
the chemical point of view, it is used with confidence by some
people for chest diseases; sometimes, one prescribes crude
snails. In this form, it is a disgusting remedy’ (8). Figuier also
indicated that several physicians had therapeutic experience
with snails: Chrestien, Pourché, Legrand, Simon and Flin all
used the remedy for tuberculosis. The book describes useful
pharmaceutical formulations: snails, sugar, tablets, syrup, snail
paste and snail chocolate. These formulations were applied
orally and indicated for resistant colds, tuberculosis of the first
and second degrees, acute and chronic chest ailments and intes-
tinal irritations. Snail ointment is only for external use to treat
chapping and efflorescence of a sore. Figuier mentions the
properties of hélicine, a transparent yellow oil, extracted from
Helix pomatia but also from ‘all big species of snails’(8). Later,
Dr Revnes confirmed in 1874 ‘a patient having reached the last
stage of marasmus can easily digest several dozen crude snails,
even though his lazy and impaired stomach can barely support
donkey milk’(5).
The 1877 edition of Dorvault (a pharmaceutical reference
book in France at that time) also mentioned several products
based on snails: snail paste with donkey milk, Quelquejeu
snail paste, Figuier or de Mure snail pectoral paste, Figuier or
de Mure snail syrup, Figuier snail pectoral syrup, as well as
Baron-Barthelemy snail pectoral paste. Baron-Barthelemy, a
pharmacist in Beziers (Hérault, France), published a report
about the pharmaceutical formulations based on helicine thateCAM 2005;2(1) 27
found during the summer on olive trees. Analyses indicate that
these snails are different from others. They are rich in a fatty acid
derived from the natural herbs that they eat. The most famous is
the so called pourprier’(18). Actually, this is  -linolenic acid that
has been reported to have a protective effect against cardiov-
ascular diseases. Recent studies published in 2001 showed that
 -linolenic acid prevents ventricular fibrillation and reduces
platelet aggregation (19). The FDA has also shown interest in
snails. In the 1980s, American investigators from the University
of Utah evaluated hundreds of neurotoxins derived from sea
snails. These are utilized as they attack their prey or their preda-
tors and induce a neuro-muscular blockage. This is why
ziconotide (SNXIII), a synthetic peptide derived from snail
venom, has been under FDA review since 1999. Pre-clinical and
clinical studies of this new drug indicate a powerful anesthetic
effect. During controlled clinical trials, ziconotide reduced pain
intensity by 53% (compared with 18% for the placebo), even in
patients insensitive to morphine (20). In 2000, a new neurotoxin,
so-called conotoxin TVIIA, was extracted from Conus tulipa,a
fish-eating sea snail. Finally, in 2001, another peptide, the 
so-called contryphan-Vn, was extracted from the venom of a
Mediterranean snail (24).
Conclusions: Implications of Snails for CAM
This brief historical review concerning the therapeutic use
of snails reveals that from antiquity to the present, humans
have always considered snails as a source of surprising and
numerous therapeutic or biological properties. Besides snail-
based empirical formulations, a certain measure of true scientific
investigation has been performed, especially including the com-
ponents of the respiratory system including the bronchial tree and
trachea. Thus novel avenues are opening up via new information
on cardiovascular diseases but also via sea snails for pain treat-
ment, yet another approach. The anesthetic properties of sea
Conus neuropeptides are promising, thus paving the way for dis-
coveries of linkages to the nervous system.
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